Literature DB >> 2433391

The fall of homovanillic acid and 5-hydroxyindoleacetic acid concentrations in brains of mice withdrawn from repeated morphine treatment and their restoration by acute morphine administration.

L Ahtee, P Attila, V Lauhakangas, A Solkinen, J Sipilä.   

Abstract

The striatal homovanillic acid (HVA) and cerebral 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) concentrations were estimated in male mice withdrawn from 3- to 5-day morphine treatment (total dose: 1,100-2,350 mg/kg). All mice were given probenecid (200 mg/kg, 2 hours). The HVA concentration was decreased (by 26%) in mice withdrawn from 3-day treatment, but the 5-HIAA concentration fell (by 22%) only after 4-day treatment. An acute morphine dose (30 mg/kg, 2 hours) clearly elevated the HVA concentration in mice withdrawn from 4-day treatment, but mice withdrawn from 3-day treatment tended to be tolerant to the HVA concentration elevating effect of morphine. The acute dose increased the 5-HIAA concentration in mice withdrawn from 4-day treatment, by 20-40%, but the mice withdrawn from 3-day treatment were clearly tolerant to this effect of morphine. These results suggest that endogenous activities of dopaminergic and 5-HTergic neurons are attenuated by repeated morphine treatment. However, such attenuation seems to reactivate these neurons to respond to acute morphine administration nearly normally.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433391     DOI: 10.1007/bf01244640

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  22 in total

1.  Long-term morphine treatment decreases endorphin levels in rat brain and pituitary.

Authors:  R Przewłocki; V Höllt; T Duka; G Kleber; C Gramsch; I Haarmann; A Herz
Journal:  Brain Res       Date:  1979-10-05       Impact factor: 3.252

2.  Effect of probenecid on the level of homovanillic acid in the corpus striatum.

Authors:  B Werdinius
Journal:  J Pharm Pharmacol       Date:  1966-08       Impact factor: 3.765

3.  Acid monoamine metabolites in cerebrospinal fluid during methadone maintenance.

Authors:  M B Bowers; H D Kleber; L Davis
Journal:  Nature       Date:  1971-08-20       Impact factor: 49.962

4.  Dual action of methadone on 5-HT synthesis and metabolism.

Authors:  L Ahtee; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-05       Impact factor: 3.000

5.  Catalepsy and stereotyped behaviour in rats treated chronically with methadone: relation to brain homovanillic acid content.

Authors:  L Ashtee
Journal:  J Pharm Pharmacol       Date:  1973-08       Impact factor: 3.765

6.  Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma.

Authors:  N H Neef; T N Tozer; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1967-11       Impact factor: 4.030

7.  Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.

Authors:  D F Sharman
Journal:  Br J Pharmacol Chemother       Date:  1966-11

8.  Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.

Authors:  L M Attila; L Ahtee
Journal:  Med Biol       Date:  1983

9.  Acid metabolites of monoamines in avian brain; effects of probenecid and reserpine.

Authors:  L Ahtee; D F Sharman; M Vogt
Journal:  Br J Pharmacol       Date:  1970-01       Impact factor: 8.739

10.  Similarities and differences between D-ALA2 MET5 enkephalin amide and morphine in the induction of tolerance to their effects on catalepsy and on dopamine metabolism in the rat brain.

Authors:  M G De Simoni; V Guardabasso; K Misterek; S Algeri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

View more
  3 in total

1.  Simultaneous measurement of biogenic amines and their metabolites in rat brain regions after acute administration of and abrupt withdrawal from butorphanol or morphine.

Authors:  H Wakabayashi; S Tokuyama; I K Ho
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

2.  The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment.

Authors:  J Airio; L Ahtee
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

3.  Withdrawal from repeated morphine sensitizes mice to the striatal dopamine release enhancing effect of acute morphine.

Authors:  J Airio; M Attila; T Leikola-Pelho; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.